# Risks and Limitations: LAB-033

**Analysis Date**: 2026-07-22
**Experiment**: LAB-033
**Status**: COMPLETE

---

## Risks

### Risk 1: Implementation Complexity Underestimated

| Attribute | Description |
|-----------|-------------|
| Risk | Actual implementation effort exceeds estimates |
| Likelihood | MEDIUM |
| Impact | MEDIUM |
| Mitigation | Phase implementation with checkpoints |
| Contingency | Reduce scope, prioritize P1 only |

**Assessment**: All complexity estimates are based on analysis, not implementation. Actual effort may differ.

---

### Risk 2: False Positives

| Attribute | Description |
|-----------|-------------|
| Risk | Validation produces warnings/errors for valid artifacts |
| Likelihood | HIGH |
| Impact | MEDIUM |
| Mitigation | Tune thresholds, allow bypass for documented exceptions |
| Contingency | Add exception mechanism |

**Assessment**: Pattern matching and schema validation may not handle all edge cases.

---

### Risk 3: False Negatives

| Attribute | Description |
|-----------|-------------|
| Risk | Validation passes for invalid artifacts |
| Likelihood | MEDIUM |
| Impact | MEDIUM |
| Mitigation | Multiple validation layers |
| Contingency | Human review remains mandatory |

**Assessment**: Deterministic rules cannot catch all issues.

---

### Risk 4: Validation Slowdown

| Attribute | Description |
|-----------|-------------|
| Risk | Validation adds unacceptable latency to pipeline |
| Likelihood | LOW |
| Impact | LOW |
| Mitigation | Async validation where possible, parallel execution |
| Contingency | Make validation optional per experiment |

**Assessment**: Validators are simple comparisons; should not significantly impact performance.

---

### Risk 5: Schema Evolution

| Attribute | Description |
|-----------|-------------|
| Risk | Schema changes break existing validation |
| Likelihood | LOW |
| Impact | MEDIUM |
| Mitigation | Version schemas, backward compatibility |
| Contingency | Validation version negotiation |

**Assessment**: Schema changes should be infrequent with governance process.

---

### Risk 6: Over-Validation

| Attribute | Description |
|-----------|-------------|
| Risk | Excessive validation creates friction, reduces productivity |
| Likelihood | MEDIUM |
| Impact | MEDIUM |
| Mitigation | WARNING vs ERROR distinction, allow experiment override |
| Contingency | Reduce validation scope |

**Assessment**: Balance between rigor and usability is subjective.

---

### Risk 7: Schema Definition Gaps

| Attribute | Description |
|-----------|-------------|
| Risk | Schemas do not cover all edge cases |
| Likelihood | HIGH |
| Impact | LOW |
| Mitigation | Iterative schema refinement |
| Contingency | Add cases as discovered |

**Assessment**: Initial schemas will be incomplete.

---

### Risk 8: Circular Dependencies

| Attribute | Description |
|-----------|-------------|
| Risk | Validators depend on each other, creating resolution order issues |
| Likelihood | LOW |
| Impact | MEDIUM |
| Mitigation | Clear dependency ordering, independent validators first |
| Contingency | Reorder validation stages |

**Assessment**: Dependency analysis complete; ordering is clear.

---

### Risk 9: Human Review Over-reliance

| Attribute | Description |
|-----------|-------------|
| Risk | Validation encourages over-reliance on automated checks |
| Likelihood | MEDIUM |
| Impact | HIGH |
| Mitigation | Maintain human review requirement |
| Contingency | Reinforce human review mandates |

**Assessment**: Validation should augment, not replace, human review.

---

### Risk 10: Implementation Scope Creep

| Attribute | Description |
|-----------|-------------|
| Risk | Additional capabilities added beyond scope |
| Likelihood | MEDIUM |
| Impact | LOW |
| Mitigation | Strict scope management |
| Contingency | New capabilities = new investigation |

**Assessment**: Investigation recommends 9 capabilities; implementation should not expand without justification.

---

## Limitations

### Limitation 1: Analysis-Based Only

| Attribute | Description |
|-----------|-------------|
| Limitation | This investigation is analysis only; no implementation to verify recommendations |
| Impact | Unknown accuracy of effort/cost estimates |
| Mitigation | Recommend pilot implementation |

**Note**: This is an architectural investigation, not an implementation.

---

### Limitation 2: Single Experiment Evidence

| Attribute | Description |
|-----------|-------------|
| Limitation | Gap analysis based on single experiment (LAB-031) |
| Impact | May not identify all required capabilities |
| Mitigation | Recommend broader experiment analysis |

**Note**: LAB-031 provided evidence; broader analysis would strengthen findings.

---

### Limitation 3: No Technology Assessment

| Attribute | Description |
|-----------|-------------|
| Limitation | No assessment of technology stack for implementation |
| Impact | Unknown feasibility of specific approaches |
| Mitigation | Technology choices deferred to implementation |

**Note**: This investigation defines WHAT, not HOW.

---

### Limitation 4: Human Judgment Not Validated

| Attribute | Description |
|-----------|-------------|
| Limitation | Whether human review catches issues validation would catch is unknown |
| Impact | Unknown validation effectiveness |
| Mitigation | Measure after implementation |

**Note**: Assumes validation catches issues humans miss; not verified.

---

### Limitation 5: Schema Completeness Unknown

| Attribute | Description |
|-----------|-------------|
| Limitation | Whether proposed schemas are complete is unknown |
| Impact | May need significant schema revision |
| Mitigation | Iterative schema development |

**Note**: Initial schemas will be incomplete; refinement required.

---

### Limitation 6: No Cost-Benefit Analysis

| Attribute | Description |
|-----------|-------------|
| Limitation | No quantitative cost-benefit analysis performed |
| Impact | Unknown return on implementation investment |
| Mitigation | Recommend cost estimation during implementation |

**Note**: Implementation effort estimated qualitatively.

---

### Limitation 7: Validation Cannot Catch All Issues

| Attribute | Description |
|-----------|-------------|
| Limitation | Deterministic validation cannot catch semantic errors |
| Impact | Some issues will remain undetected |
| Mitigation | Maintain human review as backstop |

**Note**: Validation is probabilistic improvement, not perfect solution.

---

### Limitation 8: Generalizability Unknown

| Attribute | Description |
|-----------|-------------|
| Limitation | Whether capabilities generalize to all experiment types unknown |
| Impact | May need specialized validation per domain |
| Mitigation | Recommend domain-specific validation extensions |

**Note**: Analysis focused on general experiment structure.

---

## Risk Summary Table

| Risk | Likelihood | Impact | Priority |
|------|------------|--------|----------|
| False Positives | HIGH | MEDIUM | P1 |
| Schema Definition Gaps | HIGH | LOW | P2 |
| Implementation Scope Creep | MEDIUM | LOW | P2 |
| Over-Validation | MEDIUM | MEDIUM | P2 |
| False Negatives | MEDIUM | MEDIUM | P3 |
| Human Review Over-reliance | MEDIUM | HIGH | P3 |
| Complexity Underestimated | MEDIUM | MEDIUM | P3 |
| Schema Evolution | LOW | MEDIUM | P4 |
| Validation Slowdown | LOW | LOW | P4 |
| Circular Dependencies | LOW | MEDIUM | P4 |

---

## Future Investigation Recommendations

Based on identified risks and limitations:

| # | Recommendation | Rationale |
|---|-----------------|-----------|
| 1 | Pilot implementation of P1 capabilities | Verify feasibility, adjust estimates |
| 2 | Analyze additional experiments | Strengthen gap analysis |
| 3 | Technology assessment | Evaluate implementation approaches |
| 4 | Cost-benefit analysis | Quantify implementation value |
| 5 | Schema iteration plan | Define schema evolution process |
| 6 | Validation effectiveness study | Measure human vs. validation catch rate |

---

*Document Status*: COMPLETE
*Evidence Type*: analysis
*Confidence*: MEDIUM (limitations acknowledged)
